Michael L. Meyers Syndax Pharmaceuticals Inc (SNDX) insider trading activity
Michael L. Meyers is SVP, Chief Medical Officer of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 23,280 shares of SNDX, which is worth approximately $441,854. The most recent transaction as insider was on Jan 31, 2022, when has been sold 1,714 shares (Common Stock) at a price of $12.39 per share, resulting in proceeds of $21,236. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
23.3K
0%
3M change
0%
12M change
Total Value Held
$441,854
Michael L. Meyers Transaction History
Also insider at
MLM
Michael L. Meyers
SVP, Chief Medical Officer
Waltham, MA